EGFR and non-small cell lung carcinoma: In conclusion, chemotherapy plus ICI as first‐line therapy might not yield a better survival benefit than chemotherapy alone or in combination with angiogenesis inhibitors in advanced NSCLC with EGFR ex20ins.